TECH
Bio-Techne Corporation Healthcare - Life Sciences Investor Relations →
Bio-Techne Corporation (TECH) closed at $51.48 as of 2026-03-20, trading 26.7% below its 200-week moving average of $70.23. This places TECH in the extreme value zone. The stock moved further from the line this week, up from -27.8% last week. The 14-week RSI sits at 41, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.00 ratio) is neutral — neither side is clearly dominating.
Over the past 1888 weeks of data, TECH has crossed below its 200-week moving average 18 times. On average, these episodes lasted 16 weeks. Historically, investors who bought TECH at the start of these episodes saw an average one-year return of +10.6%.
With a market cap of $8.1 billion, TECH is a mid-cap stock. The company generates a free cash flow yield of 3.2%. Return on equity stands at 4.0%. The stock trades at 4.0x book value.
Over the past 33.2 years, a hypothetical investment of $100 in TECH would have grown to $5714, compared to $2683 for the S&P 500. That represents an annualized return of 12.9% vs 10.4% for the index — confirming TECH as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: TECH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After TECH Crosses Below the Line?
Across 18 historical episodes, buying TECH when it crossed below its 200-week moving average produced an average return of +11.7% after 12 months (median +15.0%), compared to +19.3% for the S&P 500 over the same periods. 67% of those episodes were profitable after one year. After 24 months, the average return was +30.9% vs +40.9% for the index.
Each line shows $100 invested at the moment TECH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
TECH has crossed below its 200-week MA 18 times with an average 1-year return of +10.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 1994 | Feb 1995 | 32 | 13.4% | +31.7% | +9516.1% |
| Apr 2002 | May 2002 | 3 | 1.5% | -21.7% | +820.8% |
| Jul 2002 | Aug 2002 | 6 | 14.0% | +26.3% | +875.9% |
| Aug 2002 | Sep 2002 | 2 | 2.2% | +18.6% | +768.0% |
| Dec 2002 | Aug 2003 | 36 | 39.5% | +25.2% | +728.6% |
| Sep 2003 | Oct 2003 | 3 | 3.7% | +22.6% | +671.7% |
| Feb 2009 | May 2009 | 13 | 20.9% | +14.0% | +347.5% |
| May 2009 | May 2009 | 1 | 0.1% | +2.8% | +307.8% |
| Jul 2009 | Jul 2009 | 1 | 0.4% | -1.9% | +306.6% |
| May 2010 | Oct 2010 | 20 | 8.3% | +36.5% | +296.6% |
| Oct 2010 | Nov 2010 | 5 | 2.9% | +17.7% | +291.1% |
| Nov 2011 | Nov 2011 | 1 | 3.2% | +17.7% | +274.6% |
| Apr 2013 | May 2013 | 4 | 2.6% | +31.0% | +250.6% |
| Sep 2022 | Nov 2022 | 7 | 8.5% | -4.3% | -28.1% |
| Jan 2023 | Apr 2023 | 10 | 10.8% | -16.3% | -33.9% |
| Apr 2023 | May 2023 | 3 | 2.1% | -19.4% | -34.6% |
| Jun 2023 | Jul 2023 | 5 | 7.5% | -0.6% | -33.5% |
| Jul 2023 | Ongoing | 138+ | 43.1% | Ongoing | -36.5% |
| Average | 16 | — | +10.6% | — |
Frequently Asked Questions
Is TECH below its 200-week moving average?
Yes. As of 2026-03-20, Bio-Techne Corporation (TECH) is trading 26.7% below its 200-week moving average of $70.23. The current price is $51.48.
What is TECH's 200-week moving average price?
Bio-Techne Corporation's 200-week moving average is $70.23 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when TECH drops below its 200-week moving average?
TECH has crossed below its 200-week moving average 18 times in our data. On average, buying at that moment produced a one-year return of +10.6%. These dips have historically been decent entry points. These episodes lasted 16 weeks on average.
Is TECH a good value right now?
Here's what our data says about TECH as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 41. Free cash flow yield is 3.2%. Return on equity is 4.0%. Price-to-book is 4.0x. This is not a buy or sell recommendation — always do your own research.
How does TECH compare to the S&P 500?
Over the past 33.2 years, $100 invested in TECH would have grown to $5714, compared to $2683 for the S&P 500. That's 12.9% annualized vs 10.4% for the index. TECH has outperformed the broader market over this period.
Does TECH pay a dividend?
Yes. Bio-Techne Corporation currently pays a dividend yield of 62.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20